| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/05/2001 | EP1129088A2 Crystalline form of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
| 09/05/2001 | EP1129086A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 09/05/2001 | EP1129084A2 Ppar gamma ligands |
| 09/05/2001 | EP1129079A2 2,4-disubstituded triazine derivatives with anti hiv activity |
| 09/05/2001 | EP1129078A2 Indazole derivatives with 5-ht2 receptor activity |
| 09/05/2001 | EP1129077A1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 09/05/2001 | EP1129076A1 Tetrahydroisoquinoline derivatives as lhrh antagonists |
| 09/05/2001 | EP1129075A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
| 09/05/2001 | EP1129074A2 Antrhranilic acid amides and the use thereof as medicaments |
| 09/05/2001 | EP1129072A2 N-substituted azacycles, their preparation and their use as orl-1 receptor ligands |
| 09/05/2001 | EP1129070A1 Neurotrophic diamide and carbamate agents |
| 09/05/2001 | EP1129068A1 Bicyclic signal transduction inhibitors, composition containing them and uses thereof |
| 09/05/2001 | EP1129064A1 Transfection reagents |
| 09/05/2001 | EP1128845A1 Combinations comprising a beta-agonist and a further antdiabetic agent |
| 09/05/2001 | EP1128844A1 Methods for enhancing wound healing |
| 09/05/2001 | EP1128838A1 A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5 |
| 09/05/2001 | EP1128835A1 Cyanocobalamin (vitamin b 12?) treatment in allergic disease |
| 09/05/2001 | EP1128834A1 Combinations for diabetes which contain a sulfonylurea, a glitazone and a biguanide |
| 09/05/2001 | EP1128833A1 Use of agonists of glucocorticosteroid receptors and/or mineral corticosteroid receptors, especially corticosteroids to treat addictions |
| 09/05/2001 | EP1128832A1 Compounds, compositions and methods for treating or preventing viral infections and associated diseases |
| 09/05/2001 | EP1128831A1 Pharmaceutical moxifloxacin preparation |
| 09/05/2001 | EP1128830A1 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
| 09/05/2001 | EP1128829A1 Riluzole and alpha-tocopherol combination |
| 09/05/2001 | EP1128828A1 Methods for prolonging cell membrane permeability |
| 09/05/2001 | EP1128827A1 Pharmaceutical composition for modified release insulin sensitiser |
| 09/05/2001 | EP1128826A1 Chromone enteric release formulation |
| 09/05/2001 | EP1128825A1 A new composition |
| 09/05/2001 | EP1128824A1 Ionic silver complex |
| 09/05/2001 | EP1128823A1 Use of propionyl l-carnitine for the preparation of a medicament capable of inducing apoptosis |
| 09/05/2001 | EP1128822A1 Antioxidant compositioncomprising propionyl l-carnitine and a flavonoid against thrombosis and atherosclerosis |
| 09/05/2001 | EP1128820A1 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 09/05/2001 | EP1128819A1 New controlled release bead, a method of producing the same and multiple unit formulation comprising it |
| 09/05/2001 | EP1128817A1 Microparticles containing peg and/or peg glyceryl esters |
| 09/05/2001 | EP1128815A1 Process for preparing oral calcium compositions |
| 09/05/2001 | EP1128814A1 Aerosols comprising nanoparticle drugs |
| 09/05/2001 | EP1128813A1 An inhalation system |
| 09/05/2001 | EP1128812A1 Nano-emulsion of 5-aminolevulinic acid |
| 09/05/2001 | EP1128811A1 Drug delivery device, especially for the delivery of progestins and estrogens |
| 09/05/2001 | EP1128810A1 Drug delivery device, especially for the delivery of androgens |
| 09/05/2001 | EP1128802A1 Low-irritation antiperspirant and deodorant compositions |
| 09/05/2001 | EP1128784A1 Therapeutic use of polymers |
| 09/05/2001 | EP1128738A1 A method for supplying bioavailable methionine to a cow |
| 09/05/2001 | EP1128730A1 Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the n-hydroxyanilide-type |
| 09/05/2001 | EP1128727A1 Method for treating a patient with neoplasia by treatment with a paclitaxel derivative |
| 09/05/2001 | EP1128726A1 Teat disinfectant |
| 09/05/2001 | EP1128725A1 Disposable premoistened wipe containing an antimicrobial protease inhibitor |
| 09/05/2001 | EP1070057A4 7-hexanoyltaxol and methods for preparing the same |
| 09/05/2001 | EP1059889A4 Treatment of brain edema using carbonic anhydrase enzyme inhibitor |
| 09/05/2001 | EP1028705B1 Uses of d-xylose, the esters thereof and oligosaccharides containing xylose for improving the functionality of epidermal cells |
| 09/05/2001 | EP1025088B1 Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
| 09/05/2001 | EP1000075A4 Method of producing tiazofurin and other c-nucleosides |
| 09/05/2001 | EP0959888B1 Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease |
| 09/05/2001 | EP0946545B1 Novel carboxy substituted cyclic carboxamide derivatives |
| 09/05/2001 | EP0944612B1 N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate |
| 09/05/2001 | EP0879249B1 Modified inulin |
| 09/05/2001 | EP0873304B1 Metalloproteinase inhibitors |
| 09/05/2001 | EP0869767B1 Cosmetic compositions for the hair or skin based on sulfone copolyesters with polyorganosiloxane units |
| 09/05/2001 | EP0868423B1 Method for the synthesis of a benzimidazole compound |
| 09/05/2001 | EP0862556B1 17-alkyl-7-substituted-4-aza steroid derivatives |
| 09/05/2001 | EP0832061B1 Benzamide derivatives and their use as vasopressin antagonists |
| 09/05/2001 | EP0830345B1 Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation |
| 09/05/2001 | EP0828733B1 Benzopyrans and pharmaceutical compositions containing them |
| 09/05/2001 | EP0807112B1 Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials |
| 09/05/2001 | EP0804162B1 Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation |
| 09/05/2001 | EP0801527A4 Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
| 09/05/2001 | EP0799038B1 NEW USES OF INDOLO-[2,3b]-QUINOXALINES |
| 09/05/2001 | EP0793646B1 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus |
| 09/05/2001 | EP0777646B1 Metalloproteinase inhibitors |
| 09/05/2001 | EP0731708B1 Extract from the leaves of ginkgo biloba |
| 09/05/2001 | EP0699185B1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS |
| 09/05/2001 | EP0637300B1 Antiproliferative quinazolines |
| 09/05/2001 | EP0632809B1 Quinuclidine derivatives as substance p antagonists |
| 09/05/2001 | EP0630374B1 Imidazole, triazole and tetrazole derivatives |
| 09/05/2001 | EP0574510B1 2,4-diaryl-1,3-dithiolanes as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
| 09/05/2001 | CN1311793A Antipicornaviral compounds, their prepn. and use |
| 09/05/2001 | CN1311792A Meiosis regulating compound |
| 09/05/2001 | CN1311790A Novel C-2 5/O-and S/N formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and beta lactamase inhibitors |
| 09/05/2001 | CN1311789A Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity |
| 09/05/2001 | CN1311787A Oxazolidinone derivatives, process for their prepn. and pharmaceutical compositions contg. same |
| 09/05/2001 | CN1311785A Tetrahydroquinoline derivatives as glycine antagonists |
| 09/05/2001 | CN1311779A Succinoylamino lactams as inhibitors and as A beta protein production |
| 09/05/2001 | CN1311777A High affinity ligands for nociceptin receptor ORL-1 |
| 09/05/2001 | CN1311776A Quanternary ammonium compounds as anti-tussive agents |
| 09/05/2001 | CN1311775A Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 09/05/2001 | CN1311773A Neuropeptide Y5 receptor antagonists |
| 09/05/2001 | CN1311772A New 3-aryl-2-hydoxy-propionic acid derivative I |
| 09/05/2001 | CN1311770A Derivatives of alpha-amino acid phenyl ester |
| 09/05/2001 | CN1311769A New 3-aryl-2-hydroxypropionic acid derivative III |
| 09/05/2001 | CN1311767A Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 09/05/2001 | CN1311692A Farnesyl protein transferase inhibitors with i(IN VIVO) Radiosensitizing |
| 09/05/2001 | CN1311686A Pulmonary delivery of active agents |
| 09/05/2001 | CN1311685A Composite biocidal particles |
| 09/05/2001 | CN1311684A Propylactic treatments of neovascularisation in macular degeneration |
| 09/05/2001 | CN1311683A Use of biogenic estrogen sulfamates for hormone replacement therapy |
| 09/05/2001 | CN1311682A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17 beta-diol |
| 09/05/2001 | CN1311681A combination therepy for treatment of refractory depression |
| 09/05/2001 | CN1311680A Pyrrolo [2,3d] pyrimidine compositions and their use |
| 09/05/2001 | CN1311679A Benzimidazole derivatives as modulators of IgE |
| 09/05/2001 | CN1311678A Substituted tricyclic pyrazole derivatives with protein kinase activity |
| 09/05/2001 | CN1311677A Remedies or preventives for intractable epilepsy |